Share on StockTwits

Muscle Pharm Co.. (NASDAQ:MSLP) CEO Brad J. Pyatt acquired 2,500 shares of the company’s stock on the open market in a transaction dated Thursday, August 14th. The stock was purchased at an average price of $11.48 per share, with a total value of $28,700.00. Following the acquisition, the chief executive officer now directly owns 558,222 shares in the company, valued at approximately $6,408,389. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Muscle Pharm Co.. (NASDAQ:MSLP) traded up 4.55% during mid-day trading on Friday, hitting $11.50. 50,588 shares of the company’s stock traded hands. Muscle Pharm Co.. has a 1-year low of $6.16 and a 1-year high of $12.40. The stock’s 50-day moving average is $11.55 and its 200-day moving average is $9.01. The company’s market cap is $128.0 million.

Muscle Pharm Co.. (NASDAQ:MSLP) last announced its earnings results on Monday, August 4th. The company reported $0.03 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.08) by $0.11. Analysts expect that Muscle Pharm Co.. will post $0.20 EPS for the current fiscal year.

MusclePharm Corporation (NASDAQ:MSLP) is engaged in the business of providing personal fitness training using isometric techniques (Tone in Twenty).

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.